Reviva Pharmaceuticals Holdings, Inc. (RVPH)

RVPH Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.19	14.44	13.48	23.37	18.52	29.69
Cash & Short-Term Investments	22.19	14.44	13.48	23.37	18.52	29.69
Cash Growth	319.52%	7.14%	-42.33%	26.17%	-37.62%	238.89%
Prepaid Expenses	1.37	0.66	1.21	0.33	0.4	1.72
Total Current Assets	23.56	15.1	14.68	23.7	18.92	31.4
Other Long-Term Assets	-	0.82	0.82	-	-	-
Total Assets	23.56	15.92	15.5	23.7	18.92	31.4
Accounts Payable	2.09	3.01	6.28	3.85	3.52	0.51
Accrued Expenses	3.08	3.86	7.86	12.93	6.14	1.84
Short-Term Debt	0.23	0.41	0.46	-	-	-
Other Current Liabilities	0.72	-	-	0.4	0.3	-
Total Current Liabilities	6.12	7.28	14.6	17.18	9.96	2.34
Other Long-Term Liabilities	-	-	0.09	0.81	0.57	0.37
Total Liabilities	6.12	7.28	14.69	17.98	10.53	2.72
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	204.76	192.77	165.08	140.07	103.49	95.52
Retained Earnings	-187.33	-184.14	-164.27	-134.35	-95.09	-66.83
Total Common Equity	17.44	8.65	0.81	5.72	8.39	28.69
Shareholders' Equity	17.44	8.65	0.81	5.72	8.39	28.69
Total Liabilities & Equity	23.56	15.92	15.5	23.7	18.92	31.4
Total Debt	0.23	0.41	0.46	-	-	-
Net Cash (Debt)	21.96	14.03	13.02	23.37	18.52	29.69
Net Cash Growth	333.53%	7.79%	-44.29%	26.17%	-37.62%	238.89%
Net Cash Per Share	4.61	3.87	7.71	19.64	18.98	40.14
Filing Date Shares Outstanding	13.11	12.81	2.34	1.4	1.02	0.76
Total Common Shares Outstanding	12.81	5.87	2.33	1.4	1.02	0.72
Working Capital	17.44	7.83	0.08	6.53	8.96	29.06
Book Value Per Share	1.36	1.47	0.35	4.10	8.21	39.75
Tangible Book Value	17.44	8.65	0.81	5.72	8.39	28.69
Tangible Book Value Per Share	1.36	1.47	0.35	4.10	8.21	39.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.